InterCure INCR Stock
1.48 USD
{{ price }}
8.823529%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
69.8M USD
LOW - HIGH [24H]
1.39
-
1.49 USD
VOLUME [24H]
17K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.39 USD
InterCure Price Chart
InterCure INCR Financial and Trading Overview
| InterCure stock price | 1.48 USD |
| Previous Close | 2.09 USD |
| Open | 2.12 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 3200 |
| Day's Range | 2.12 - 2.16 USD |
| 52 Week Range | 1.73 - 6.57 USD |
| Volume | 8.45K USD |
| Avg. Volume | 49.67K USD |
| Market Cap | 100.81M USD |
| Beta (5Y Monthly) | -0.132534 |
| PE Ratio (TTM) | 13.312501 |
| EPS (TTM) | -0.39 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.56 USD |
INCR Valuation Measures
| Enterprise Value | 95.25M USD |
| Trailing P/E | 13.312501 |
| Forward P/E | 1.717742 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
InterCure Stock Price History
| Beta (5Y Monthly) | -0.132534 |
| 52-Week Change | -62.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.57 USD |
| 52 Week Low | 1.73 USD |
| 50-Day Moving Average | 2.24 USD |
| 200-Day Moving Average | 3.51 USD |
INCR Share Statistics
| Avg. Volume (3 month) | 49.67K USD |
| Avg. Daily Volume (10-Days) | 17.48K USD |
| Shares Outstanding | 45.57M |
| Float | 29.43M |
| Short Ratio | 0.64 |
| % Held by Insiders | 35.79% |
| % Held by Institutions | 8.69% |
| Shares Short | 35.02K |
| Short % of Float | 0.13% |
| Short % of Shares Outstanding | 0.080% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 7.76% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 41.85% |
| EBITDA Margin | 8.60% |
Management Effectiveness
| Return on Assets (ttm) | 2.06% |
| Return on Equity (ttm) | 5.78% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 21.69% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 0.16 |
| Quarterly Earnings Growth (yoy) | -98.40% |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 37.31 USD |
| Current Ratio (mrq) | 1.825 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of InterCure
| Country | United States |
| State | N/A |
| City | Herzliya |
| Address | 85 Medinat ha-Yehudim Street |
| ZIP | 4676670 |
| Phone | 972 7 746 05012 |
| Website | https://www.intercure.co |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 370 |
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Q&A For InterCure Stock
What is a current INCR stock price?
InterCure INCR stock price today per share is 1.48 USD.
How to purchase InterCure stock?
You can buy INCR shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for InterCure?
The stock symbol or ticker of InterCure is INCR.
Which industry does the InterCure company belong to?
The InterCure industry is Drug Manufacturers-Specialty & Generic.
How many shares does InterCure have in circulation?
The max supply of InterCure shares is 47.16M.
What is InterCure Price to Earnings Ratio (PE Ratio)?
InterCure PE Ratio is now.
What was InterCure earnings per share over the trailing 12 months (TTM)?
InterCure EPS is -0.39 USD over the trailing 12 months.
Which sector does the InterCure company belong to?
The InterCure sector is Healthcare.
InterCure INCR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Composite Total Return I XCMP | 21278.67 USD — |
+1.26
|
— — | 20945.45 USD — | 21305.05 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4470.08 USD — |
-1.41
|
— — | 4446.23 USD — | 4506.67 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1839.71 USD — |
-3.16
|
— — | 1825.54 USD — | 1881.06 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}